177 related articles for article (PubMed ID: 24279419)
1. Large-scale analysis of somatic hypermutations in antibodies reveals which structural regions, positions and amino acids are modified to improve affinity.
Burkovitz A; Sela-Culang I; Ofran Y
FEBS J; 2014 Jan; 281(1):306-19. PubMed ID: 24279419
[TBL] [Abstract][Full Text] [Related]
2. Trends in antibody sequence changes during the somatic hypermutation process.
Clark LA; Ganesan S; Papp S; van Vlijmen HW
J Immunol; 2006 Jul; 177(1):333-40. PubMed ID: 16785529
[TBL] [Abstract][Full Text] [Related]
3. Why does somatic hypermutation by AID require transcription of its target genes?
Storb U
Adv Immunol; 2014; 122():253-77. PubMed ID: 24507160
[TBL] [Abstract][Full Text] [Related]
4. Contribution of heavy chain junctional amino acid diversity to antibody affinity among p-azophenylarsonate-specific antibodies.
Parhami-Seren B; Margolies MN
J Immunol; 1996 Sep; 157(5):2066-72. PubMed ID: 8757328
[TBL] [Abstract][Full Text] [Related]
5. Analysis of 6912 unselected somatic hypermutations in human VDJ rearrangements reveals lack of strand specificity and correlation between phase II substitution rates and distance to the nearest 3' activation-induced cytidine deaminase target.
Ohm-Laursen L; Barington T
J Immunol; 2007 Apr; 178(7):4322-34. PubMed ID: 17371989
[TBL] [Abstract][Full Text] [Related]
6. Critical binding site amino acids of anti-Z-DNA single chain Fv molecules. Role of heavy and light chain CDR3 and relationship to autoantibody activity.
Polymenis M; Stollar BD
J Immunol; 1994 Jun; 152(11):5318-29. PubMed ID: 8189049
[TBL] [Abstract][Full Text] [Related]
7. Somatic diversity in CDR3 loops allows single V-genes to encode innate immunological memories for multiple pathogens.
Thomson CA; Little KQ; Reason DC; Schrader JW
J Immunol; 2011 Feb; 186(4):2291-8. PubMed ID: 21228346
[TBL] [Abstract][Full Text] [Related]
8. The amino acid residues at the VH-D-JH junctions affect the affinity of anti-p-azophenylarsonate antibodies.
Parhami-Seren B; Wysocki L; Margolies MN
J Immunol; 1989 Dec; 143(12):4090-7. PubMed ID: 2512349
[TBL] [Abstract][Full Text] [Related]
9. Structural elements controlling anti-DNA antibody affinity and their relationship to anti-phosphorylcholine activity.
Pewzner-Jung Y; Simon T; Eilat D
J Immunol; 1996 Apr; 156(8):3065-73. PubMed ID: 8609430
[TBL] [Abstract][Full Text] [Related]
10. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation.
Basu U; Chaudhuri J; Alpert C; Dutt S; Ranganath S; Li G; Schrum JP; Manis JP; Alt FW
Nature; 2005 Nov; 438(7067):508-11. PubMed ID: 16251902
[TBL] [Abstract][Full Text] [Related]
11. The Use of Somatic Hypermutation for the Affinity Maturation of Therapeutic Antibodies.
Bowers PM; Boyle WJ; Damoiseaux R
Methods Mol Biol; 2018; 1827():479-489. PubMed ID: 30196512
[TBL] [Abstract][Full Text] [Related]
12. Recombinase-mediated cassette exchange as a novel method to study somatic hypermutation in Ramos cells.
Baughn LB; Kalis SL; MacCarthy T; Wei L; Fan M; Bergman A; Scharff MD
mBio; 2011; 2(5):. PubMed ID: 21990614
[TBL] [Abstract][Full Text] [Related]
13. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas.
Martin A; Bardwell PD; Woo CJ; Fan M; Shulman MJ; Scharff MD
Nature; 2002 Feb; 415(6873):802-6. PubMed ID: 11823785
[TBL] [Abstract][Full Text] [Related]
14. Structural properties and mutation patterns of anti-nucleosome monoclonal antibodies are similar to those of anti-DNA antibodies.
Brard F; Jovelin F; Petit S; Tron F; Gilbert D
Eur J Immunol; 1996 Jul; 26(7):1587-94. PubMed ID: 8766565
[TBL] [Abstract][Full Text] [Related]
15. Targets of somatic hypermutation within immunoglobulin light chain genes in zebrafish.
Marianes AE; Zimmerman AM
Immunology; 2011 Feb; 132(2):240-55. PubMed ID: 21070232
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of immunoglobulin V-region diversification regulated by transcription and RNA metabolism in antigen-driven B cells.
Sakaguchi N; Maeda K; Kuwahara K
Scand J Immunol; 2011 Jun; 73(6):520-6. PubMed ID: 21388430
[TBL] [Abstract][Full Text] [Related]
17. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
18. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
Polymenis M; Stollar BD
J Immunol; 1995 Mar; 154(5):2198-208. PubMed ID: 7868893
[TBL] [Abstract][Full Text] [Related]
19. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
20. Tolerance of single, but not multiple, amino acid replacements in antibody VH CDR 2: a means of minimizing B cell wastage from somatic hypermutation?
Brown M; Rittenburg MB; Chen C; Roberts VA
J Immunol; 1996 May; 156(9):3285-91. PubMed ID: 8617951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
